Naoshi Sugimoto

2.9k total citations · 1 hit paper
48 papers, 2.0k citations indexed

About

Naoshi Sugimoto is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Naoshi Sugimoto has authored 48 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 18 papers in Molecular Biology and 16 papers in Immunology. Recurrent topics in Naoshi Sugimoto's work include Platelet Disorders and Treatments (13 papers), Pluripotent Stem Cells Research (9 papers) and Immune Cell Function and Interaction (7 papers). Naoshi Sugimoto is often cited by papers focused on Platelet Disorders and Treatments (13 papers), Pluripotent Stem Cells Research (9 papers) and Immune Cell Function and Interaction (7 papers). Naoshi Sugimoto collaborates with scholars based in Japan, United States and Netherlands. Naoshi Sugimoto's co-authors include Shimon Sakaguchi, Takashi Nomura, Keiji Hirota, Shinji Maeda, Hiromu Ito, Motomu Hashimoto, Hiroyuki Yoshitomi, Takashi Nakamura, Noriko Sakaguchi and Tomoyuki Yamaguchi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Naoshi Sugimoto

45 papers receiving 2.0k citations

Hit Papers

Preferential recruitment of CCR6-expressing Th17 cells to... 2007 2026 2013 2019 2007 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model
    2007 749 citations Keiji Hirota, Hiroyuki Yoshitomi et al. The Journal of Experimental Medicine profile →

Peers

Naoshi Sugimoto
Joachim R. Grün Germany
Silvia Monticelli Switzerland
Naoko Seki Japan
Ingmar Heijnen Switzerland
Andrew Getahun United States
David A. Mancardi France
Judy Geissler Netherlands
Florian Weisel United States
Alasdair R. Fraser United Kingdom
Dimitris Skokos United States
Joachim R. Grün Germany
Naoshi Sugimoto
Citations per year, relative to Naoshi Sugimoto Naoshi Sugimoto (= 1×) peers Joachim R. Grün

Countries citing papers authored by Naoshi Sugimoto

Since Specialization
Citations

This map shows the geographic impact of Naoshi Sugimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoshi Sugimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoshi Sugimoto more than expected).

Fields of papers citing papers by Naoshi Sugimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoshi Sugimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoshi Sugimoto. The network helps show where Naoshi Sugimoto may publish in the future.

Co-authorship network of co-authors of Naoshi Sugimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Naoshi Sugimoto. A scholar is included among the top collaborators of Naoshi Sugimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoshi Sugimoto. Naoshi Sugimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Qihao, Sou Nakamura, Takuya Yamamoto, et al.. (2025). KCNN4-mediated potassium ion efflux maintains mitochondrial functions leading to platelet biogenesis. Journal of Thrombosis and Haemostasis. 23(9). 2926–2943.
2.
Hashimoto, Kazuya, Karin Hayashi, Mio Kabata, et al.. (2024). A let-7 microRNA-RALB axis links the immune properties of iPSC-derived megakaryocytes with platelet producibility. Nature Communications. 15(1). 2588–2588. 6 indexed citations
3.
Sugimoto, Naoshi, et al.. (2022). Ex vivo manufacturing of platelets: beyond the first-in-human clinical trial using autologous iPSC-platelets. International Journal of Hematology. 117(3). 349–355. 9 indexed citations
4.
Nakamura, Sou, Naoshi Sugimoto, S. Kihara, et al.. (2021). Extracellular laminin regulates hematopoietic potential of pluripotent stem cells through integrin β1-ILK-β-catenin-JUN axis. Stem Cell Research. 53. 102287–102287. 11 indexed citations
5.
Sugimoto, Naoshi & Koji Eto. (2021). Generation and manipulation of human iPSC-derived platelets. Cellular and Molecular Life Sciences. 78(7). 3385–3401. 19 indexed citations
6.
Sone, Masamitsu, Sou Nakamura, Motohiko Oshima, et al.. (2021). Silencing of p53 and CDKN1A establishes sustainable immortalized megakaryocyte progenitor cells from human iPSCs. Stem Cell Reports. 16(12). 2861–2870. 9 indexed citations
7.
Morishima, Tatsuya, et al.. (2021). Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity. Frontiers in Immunology. 12. 662360–662360. 38 indexed citations
8.
Imataki, Osamu, et al.. (2020). Oncolytic herpes simplex virus type 1 (HSV‐1) in combination with lenalidomide for plasma cell neoplasms. British Journal of Haematology. 192(2). 343–353. 17 indexed citations
9.
Heike, Toshio, Naoshi Sugimoto, Osamu Imataki, et al.. (2020). Oncolytic Virus Therapy with HSV-1 for Hematological Malignancies. Molecular Therapy. 29(2). 762–774. 26 indexed citations
10.
Sugimoto, Naoshi, et al.. (2020). La culture de plaquettes à partir de cellules souches pluripotentes induites. Bulletin de l Académie Nationale de Médecine. 204(9). 961–970. 1 indexed citations
11.
Nakamura, Sou, Naoshi Sugimoto, & Koji Eto. (2020). Ex vivo generation of platelet products from human iPS cells. Inflammation and Regeneration. 40(1). 30–30. 12 indexed citations
12.
Suzuki, Daisuke, Yoshikazu Hayashi, Akira Sawaguchi, et al.. (2019). iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity. Stem Cell Reports. 14(1). 49–59. 48 indexed citations
13.
Heike, Toshio, et al.. (2019). Anti-inflammatory modulation of human myeloid-derived dendritic cell subsets by lenalidomide. Immunology Letters. 211. 41–48. 12 indexed citations
14.
Sugimoto, Naoshi & Koji Eto. (2017). Platelet production from induced pluripotent stem cells. Journal of Thrombosis and Haemostasis. 15(9). 1717–1727. 48 indexed citations
15.
Ishiyama, Ken, June Takeda, Naoshi Sugimoto, et al.. (2016). Feasibility of salvage cord blood transplantation following fludarabine, melphalan and low-dose TBI for graft rejection after hematopoietic stem cell transplantation. Bone Marrow Transplantation. 51(7). 985–987. 2 indexed citations
16.
Mitoma, Hiroki, Shino Hanabuchi, Tae Il Kim, et al.. (2013). The DHX33 RNA Helicase Senses Cytosolic RNA and Activates the NLRP3 Inflammasome. Immunity. 39(1). 123–135. 172 indexed citations
17.
Hirota, Keiji, Hiroyuki Yoshitomi, Motomu Hashimoto, et al.. (2007). Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. The Journal of Experimental Medicine. 204(12). 2803–2812. 749 indexed citations breakdown →
18.
Kadowaki, Norimitsu, Naoshi Sugimoto, Naotomo Kambe, et al.. (2006). IgE-activated mast cells in combination with pro-inflammatory factors induce Th2-promoting dendritic cells. International Immunology. 18(12). 1789–1799. 62 indexed citations
19.
Watanabe, Naoko, Takayuki Takahashi, Naoshi Sugimoto, et al.. (2005). Excellent response of chemotherapy-resistant B-cell-type chronic lymphocytic leukemia with meningeal involvement to rituximab. International Journal of Clinical Oncology. 10(5). 357–361. 19 indexed citations
20.
Yanai, Machi, Akinori Maeda, Naoko Watanabe, et al.. (2004). Successful Treatment of µ-Heavy Chain Disease with Fludarabine Monophosphate: A Case Report. International Journal of Hematology. 79(2). 174–177. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joachim R. Grün Breakdown of academic impact, for papers by Silvia Monticelli Breakdown of academic impact, for papers by Naoko Seki Breakdown of academic impact, for papers by Ingmar Heijnen Breakdown of academic impact, for papers by Andrew Getahun Breakdown of academic impact, for papers by David A. Mancardi Breakdown of academic impact, for papers by Judy Geissler Breakdown of academic impact, for papers by Florian Weisel Breakdown of academic impact, for papers by Alasdair R. Fraser Breakdown of academic impact, for papers by Dimitris Skokos
Rankless by CCL
2026